Patents by Inventor Hans-Paul Juretschke

Hans-Paul Juretschke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOTAM DERIVATIVES FOR THERAPEUTIC USE
    Publication number: 20170050988
    Abstract: A compound of formula (I), a stereoisomeric form thereof, or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein, is provided. The compounds of formula (I) are valuable pharmacologically active compounds and are suitable for the treatment of osteoarthritis. The preparation of the compounds of formula (I), their use as pharmaceuticals, and pharmaceutical compositions including them are also provided.
    Type: Application
    Filed: November 25, 2014
    Publication date: February 23, 2017
    Applicants: SANOFI, EUROPEAN MOLECULAR BIOLOGY LABORATORY
    Inventors: Hai-Yu HU, Marc NAZARE, Ngee HAN LIM, Danping DING-PFENNIGDORFF, Oliver PLETTENBURG, Olaf RITZELER, Hans-Paul JURETSCHKE, Joachim SAAS, Eckart BARTNIK, Peter FLORIAN, Ulrich WENDT, Carsten SCHULTZ, Hideaki NAGASE
  • USE OF HEPARINOID DERIVATIVES FOR THE TREATMENT AND DIAGNOSIS OF DISORDERS WHICH CAN BE TREATED WITH HEPARINOIDS
    Publication number: 20080249298
    Abstract: Heparinoid derivatives comprising a chelating agent which is covalently bonded to the heparinoid, and a paramagnetic metal cation from the series of transition metals Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Mo, Ru or of the lanthanides, are suitable for producing medicaments both for therapy and for diagnostic purposes, for localizing the dose employed, and for monitoring the result of treatment of disorders such as thrombosis and osteoarthrosis.
    Type: Application
    Filed: June 19, 2008
    Publication date: October 9, 2008
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Wolfgang ULMER, Hans-Paul JURETSCHKE, Christopher KERN
  • Use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
    Publication number: 20030109491
    Abstract: Heparinoid derivatives comprising a chelating agent which is covalently bonded to the heparinoid, and a paramagnetic metal cation from the series of transition metals Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Mo, Ru or of the lanthanides, are suitable for producing medicaments both for therapy and for diagnostic purposes, for localizing the dose employed, and for monitoring the result of treatment of disorders such as thrombosis and osteoarthrosis.
    Type: Application
    Filed: August 19, 2002
    Publication date: June 12, 2003
    Inventors: Wolfgang Ulmer, Hans-Paul Juretschke, Christopher Kern